Georgia Research Alliance
North America, Georgia, United States, Atlanta
Description
The Georgia Research Alliance (GRA) expands research and commercialization capacity in Georgia’s universities to launch new companies,
Investor Profile
Georgia Research Alliance has made 154 investments, with 0 in the past 12 months and 92% as lead.
Stage Focus
- Grant (92%)
- Seed (3%)
- Series A (2%)
- Debt Financing (1%)
- Series B (1%)
- Series E (1%)
- Series C (1%)
Country Focus
- United States (76%)
- Australia (4%)
'/%3e%3c/defs%3e%3cpath fill='%23012169' d='M0 0h10080v5040H0z'/%3e%3cpath stroke='%23fff' stroke-width='.6' d='m0 0 6 3m0-3L0 3' clip-path='url(%23b)' transform='scale(840)'/%3e%3cpath stroke='%23e4002b' stroke-width='.4' d='m0 0 6 3m0-3L0 3' clip-path='url(%23c)' transform='scale(840)'/%3e%3cpath stroke='%23fff' stroke-width='840' d='M2520 0v2520M0 1260h5040'/%3e%3cpath stroke='%23e4002b' stroke-width='504' d='M2520 0v2520M0 1260h5040'/%3e%3cg fill='%23fff'%3e%3cuse xlink:href='%23d' x='2520' y='3780'/%3e%3cuse xlink:href='%23a' x='7560' y='4200'/%3e%3cuse xlink:href='%23a' x='6300' y='2205'/%3e%3cuse xlink:href='%23a' x='7560' y='840'/%3e%3cuse xlink:href='%23a' x='8680' y='1869'/%3e%3cuse xlink:href='%23e' x='8064' y='2730'/%3e%3c/g%3e%3c/svg%3e)
- Sweden (3%)
- France (3%)
Industry Focus
- Health Care
- Biotechnology
- Medical
- Therapeutics
- Medical Device
- Pharmaceutical
- Health Diagnostics
- Biopharma
- Life Science
- Software
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
